[The clinical pharmacology of olitoriside].
D000328:Adult; D001161:Arteriosclerosis; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D002301:Cardiac Glycosides / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D003327:Coronary Disease / Q000188:drug therapy*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006349:Heart Valve Diseases / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009205:Myocarditis / Q000188:drug therapy*; D012214:Rheumatic Heart Disease / Q000188:drug therapy*; D013328:Strophanthins / Q000008:administration & dosage / Q000627:therapeutic use; D013610:Tachycardia / Q000150:complications
D002301:Cardiac Glycosides; D013328:Strophanthins
Klinicheskaia farmakologiia olitorizida.